No products in the cart.
Cat:GMP-h-ACRV1
* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry
Product Details
Genemedi produces core diagnostic ingredients for test of Fertility (Fertilization) and related syndrome. GeneMedi offers paired diagnostics grade acrosome protein (ACRV1) antibodies (monoclonal antibody, mab) and antigens for Fertility (Fertilization) rapid test kit of acrosome protein (ACRV1) testing in standard substance, positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT. All the antibodies and antigens for Fertility (Fertilization ) test are suitable for in functional ELISA, and other immunoassays in dignostics.The antibodies can act as a capture antibody and detection antibody. The antigens can be used as positive control.The acrosome lies between the plasma membrane in the anterior
head region and the nuclear envelope and has its own set of membranes: the
inner acrosomal membrane bordering the nuclear envelope and the outer acrosomal
membrane, which is overlaid by the plasma membrane and fuses with that
structure during acrosomal exocytosis, or the acrosome reaction. The acrosome
is derived from the Golgi complex of the spermatid. The acrosome consists of a
protein matrix core and contains numerous hydrolytic and glycolytic enzymes,
which are important for fertilization.
Product Description
Cat No. of Pruducts
GMP-h-ACRV1-Ag01:Recombinant Human ACRV1 Protein
Product Name
Recombinant Human ACRV1 Protein
Target
acrosome protein
Alias of Target/Biomarker
D11S4365, SP-10, SPACA2
Expression platform
E.coli
Isotypes
Recombinant Antigen
Bioactivity validation
acrosome protein (ACRV1) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in ACRV1 level test of Fertility (Fertilization) and related syndrome evaluation
Tag
His
Products description
Recombinant Human ACRV1 Protein was expressed in E.coli -based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.
Reconized/Reactive Species
Human
Purity
Purity: ≥95% (SDS-PAGE)
Application
Standard substance, positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA),immunonephelometry and POCT.
Formulation
Supplied as a 0.2 μM filtered solution of PBS,PH7.4.
Storage
Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.
Previous slide
Next slide
Cat No. of Pruducts
GMP-h-ACRV1-Ab01,GMP-h-ACRV1-Ab02:Anti-Human ACRV1 mouse monoclonal antibody (mAb)
Product Name
Anti-Human ACRV1 mouse monoclonal antibody (mAb)
Target
Alias of Target/Biomarker
D11S4365, SP-10, SPACA2
Expression platform
Hybridoma
Isotypes
Mouse IgG
Bioactivity validation
Human acrosome protein (ACRV1) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other acrosome protein (ACRV1) antibodies in ACRV1 level test of Fertility (Fertilization) and related syndrome evaluation.
Tag
mFc
Products description
Anti-Human ACRV1 mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by hybridoma technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other acrosome protein (ACRV1) antibodies.
Reconized/Reactive Species
Human
Purity
Purity: ≥95% (SDS-PAGE)
Application
ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT
Formulation
Supplied as a 0.2 μM filtered solution of PBS,PH7.4.
Storage
Store at? -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.
Diagnostic antibodies and antigens for cancer detection - TG, CA-125, SCC Ag, PIVKA-Ⅱ, ProGRP, Calcitonin, NSE, CA-724, HE4, CA15-3, FER, CYFRA21-1, HER2, HSP90α, S100B, CEA, AFP, sFlt-1, PSA, hEGF, TFF2, TFF3, CA199, CA50, TK1
Regardless of the advances in the cancer therapy, delayed symptoms and lack of successful diagnosis of cancer at early stage increased the death rate. Tumor-associated antigens (TAAs) and their antibodies have been identified as potential markers in cancer diagnosis and determination. TAAs and their antibodies-based detection of cancer have the advantages such as low-cost, and simple access, which attracted much attention for early cancer detection. For several reasons, tumor marker itself is typically insufficient to analyze disease conditions. Because, maximum number of markers have been produced by both normal and cancer cells. Several cancers such as anal, breast, ovaries, testicles, colon, endometrial, peritoneal, fallopian tube, gallbladder, gastric, liver, lung, neuroendocrine, pancreatic, prostate, renal, cervix, stomach and thyroid cancer, bronchopulmonary dysplasia, hepatitis, hematological malignancies, hemochromatosis, hypercalcemia, osteoporosis, Parget’s diseases and so on have been identified using specific marker. Detecting the quantity of marker proteins from different samples may benefit from ELISA, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT.
